However, specific driver mutations such as mutant IDH1 have been reported to have immunosuppressive capacities themselves by, for example, tumor-genotype dependent education of myeloid cells [133,134,135] or suppression of antitumor T cell responses [123,136,137] in the tumor microenvironment and in peripheral immune compartments [138]. The gene discussed is IDH1; the disease is neoplasm.